Graphene Turns Twenty and Celebrates by Going Commercial

Home
Graphene Turns Twenty and Celebrates by Going Commercial
June 5, 2024

Graphene Turns Twenty and Celebrates by Going Commercial

IDTechEx spoke with HydroGraph (Canada) and learned that the company’s flagship graphene product (FGA-1) has been trialled successfully by Hawkeye Bio in a biomedical sensor aimed at early detection of lung cancer. The sensor detects enzyme activity, as opposed to enzyme quantity in typical sensors, allowing improved detection of inflammatory diseases such as cancer or autoimmunity. It was stated that the “99.8% high purity and consistent geometry” of HydroGraph’s material was crucial to successful trials in the highly sensitive sensors.

Read more.

By browsing this website, you agree to our privacy policy.
I Agree